# Fabio Ciceri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fabio-ciceri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 58,944 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 117 |
| i10-index | 562 |
| Last Known Institution | Vita-Salute San Raffaele University |
| OpenAlex ID | https://openalex.org/A5026667594 |
| ORCID iD | https://orcid.org/0000-0003-0873-0123 |
| Works | 1,414 |

## Researcher papers

Showing 12 of 14.

- [Autoantibodies against type I IFNs in patients with life-threatening COVID-19](https://scholariq.org/papers/autoantibodies-against-type-i-ifns-in-patients-with-life-threatening-covid-19/)
- [Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome](https://scholariq.org/papers/lentiviral-hematopoietic-stem-cell-gene-therapy-in-patients-with-wiskott-aldrich/)
- [Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths](https://scholariq.org/papers/autoantibodies-neutralizing-type-i-ifns-are-present-in-4-of-uninfected/)
- [Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation](https://scholariq.org/papers/loss-of-mismatched-hla-in-leukemia-after-stem-cell-transplantation/)
- [Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis](https://scholariq.org/papers/microvascular-covid-19-lung-vessels-obstructive-thromboinflammatory-syndrome/)
- [Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations](https://scholariq.org/papers/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and/)
- [Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia](https://scholariq.org/papers/flotetuzumab-as-salvage-immunotherapy-for-refractory-acute-myeloid-leukemia/)
- [COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)](https://scholariq.org/papers/covid-19-infection-in-adult-patients-with-hematological-malignancies-a-european/)
- [Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy](https://scholariq.org/papers/early-predictors-of-clinical-outcomes-of-covid-19-outbreak-in-milan-italy/)
- [Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy](https://scholariq.org/papers/characteristics-treatment-outcomes-and-cause-of-death-of-invasively-ventilated/)
- [Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation](https://scholariq.org/papers/clinical-effects-of-driver-somatic-mutations-on-the-outcomes-of-patients-with/)
- [Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency](https://scholariq.org/papers/update-on-the-safety-and-efficacy-of-retroviral-gene-therapy-for/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Researcher university

- [Vita-Salute San Raffaele University](https://scholariq.org/institutions/vita-salute-san-raffaele-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.